论文信息 - A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia - 字舞流文

A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia

I. Kerridge | Angel F. Lopez | H. Ramshaw | I. Lewis | P. Marlton | A. Roberts | S. Busfield | A. Boyd | A. McLachlan | M. DeWitte | S. Durrant | D. Ritchie | G. Kennedy | K. Bradstock | T. Yeadon | M. Hertzberg | R. Basser | H. Iland | S. He | M. Barnden | Simone Bamford | Simon Z. He